Free Trial
NASDAQ:PRE

Prenetics Global Q1 2026 Earnings Results & Report

Prenetics Global logo
$16.52 -0.20 (-1.17%)
As of 11:17 AM Eastern
This is a fair market value price provided by Massive. Learn more.

Prenetics Global missed analyst expectations on both earnings and revenue in its Q1 2026 results, released June 10, 2026. The company reported EPS of -$0.56 versus the -$0.49 consensus estimate, while revenue of $35.95 million fell short of the $36 million estimate by $46.00 thousand.

Earnings Announcement Details

Quarter
Q1 2026
Report Date
Time
Before Market Opens
Conference Call
8:30 AM ET

Prenetics Global EPS Results

Actual EPS
-$0.56
Consensus EPS
-$0.49
Beat/Miss
Missed by -$0.07
One Year Ago EPS
N/A
EPS Beat Rate
5 of last 6 quarters

Prenetics Global Revenue Results

Actual Revenue
$35.95 million
Expected Revenue
$36 million
Beat/Miss
Missed by -$46.00 thousand
YoY Revenue Growth
N/A

Upcoming Earnings

Prenetics Global's Q3 2026 earnings is estimated for Wednesday, November 18, 2026, based on past reporting schedules, with a conference call scheduled at 8:30 AM ET. Check back for transcripts, audio, and key financial metrics as they become available.

Earnings Documents

Prenetics Global Q1 2026 Earnings FAQ

Prenetics Global (NASDAQ:PRE) reported earnings of -$0.56 per share for Q1 2026, missing the consensus estimate of -$0.49. The report was announced on Wednesday, June 10, 2026.

Prenetics Global reported revenue of $35.95 million for Q1 2026, against a consensus estimate of $36 million.

Prenetics Global's next earnings date is estimated for Wednesday, November 18, 2026. MarketBeat tracks confirmed and estimated earnings dates for Prenetics Global on the company's earnings history page.

Prenetics Global Earnings Headlines

PRE Announces Strategic Partnership
$0. Later: $29.97.
Bill Poulos is giving away his Simple Options Trading For Beginners book through a temporary link. Once that link expires, it returns to its usual price of $29.97. The content stays the same - plain-English lessons and a handful of proven techniques - only the price changes. Waiting means paying for something you could have gotten for free.tc pixel
Prenetics Global Names Brian Rosin to Succeed Stephen Lo as CFO
See More Prenetics Global Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Prenetics Global? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Prenetics Global and other key companies, straight to your email.

About Prenetics Global

Prenetics Global (NASDAQ:PRE) is a health sciences company focused on consumer wellness and health-related products. Its portfolio includes IM8, a consumer wellness brand offering nutritional supplements, and CircleDNA, a genetic testing service that provides reports on health, wellness and ancestry.

The company has also operated clinical genomic testing services and provided COVID-19 testing during the pandemic. Its business has since shifted toward consumer health and wellness.

Prenetics was founded in 2014 and is led by co-founder and Chief Executive Officer Danny Yeung. The company has roots in Hong Kong and has served customers in multiple markets through its testing and consumer health businesses.

View Prenetics Global Profile